|
(V1614) |
Functional and metabolic differences between male and female HUVEC |
| |
|
M. Lorenz, B. Blaschke, A. Benn, E. Hammer, E. Witt, K. Stangl, P. Knaus, V. Stangl (Berlin, Greifswald) |
|
|
Diskussion |
|
(V1615) |
Arterial Flt1 regulates de novo arteriologenesis and arteriolar caliber involving novel endothelial remodeling events |
| |
|
A. Klems, R. Wild, R. Hinkel, C. Kupatt, F. Le Noble (Karlsruhe, München) |
|
|
Diskussion |
|
(V1616) |
Importance of the Thrombomodulin – Endothelial Protein C-Receptor Interaction for New Vessel Formation Following Ischemia |
| |
|
M. Bochenek, J. Orth, S. Reyda, H. Spronk, T. Münzel, W. Ruf, K. Schäfer (Mainz; Maastricht, NL) |
|
|
Diskussion |
|
(V1617) |
The Toll-like receptor 2/6 ligand MALP-2 improves experimental collateral growth |
| |
|
A.-K. Vlacil, J. Schütt, R. Oberoi, C. Schubert, T. Schmitz-Rixen, B. Schieffer, K. Troidl, K. Grote (Marburg, Bad Nauheim, Frankfurt am Main) |
|
|
Diskussion |
|
(V1618) |
Targeting of cardiac and skeletal muscle endothelium via surface modified rAAV |
| |
|
T. Bozoglu, S. Lee, R. Hinkel, C. Kupatt (München) |
|
|
Diskussion |
|
(V1619) |
Vasorin regulates smooth muscle cell proliferation by impeding EGFR activation |
| |
|
L. Korte, R. Teske, K. Donde, J. Dutzmann, J. M. Daniel, J. Bauersachs, D. G. Sedding (Hannover, Gießen) |
|
|
Diskussion |